Dyne Therapeutics Inc. (DYN) - Insider Holders & Insider Ownership

List of insiders holdings for Dyne Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1Atlas Venture Fund XI L.P.
Atlas Venture Associates XI L.P.
Atlas Venture Associates XI LLC
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
Atlas Venture Opportunity Fund II L.P.
Atlas Venture Associates Opportunity II LP
Atlas Venture Associates Opportunity II LLC
10% Owner
2025-11-13 16:23:175,713,470
0
5,713,470Form 13G
2Forbion Capital Fund IV Cooperatief U.A.
10% Owner
2025-05-15 08:46:565,400,545
0
5,400,545Form 13G
3Kersten Dirk
Director
2026-04-23 16:15:030
4,196,573
4,196,573Form 4
4MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner
2024-02-12 16:06:323,451,303
0
3,451,303Form 13G
5Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
Atlas Venture Opportunity Fund II L.P.
Atlas Venture Associates Opportunity II LP
Atlas Venture Associates Opportunity II LLC
10% Owner
2024-03-05 17:07:001,458,691
847,388
2,306,079Form 4
6VV Manager II LLC
Vida Ventures II LLC
VIDA VENTURES II-A LLC
10% Owner
2023-02-10 16:31:312,220,034
0
2,220,034Form 13D
7Logos Global Management LP
10% Owner
2023-02-14 15:53:472,150,000
0
2,150,000Form 13G
8Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
2020-09-23 18:56:451,608,785
0
1,608,785Form 4
9Rhodes Jason P
Director
2026-04-22 18:27:220
1,285,704
1,285,704Form 4
10Brumm Joshua T
CEO & President
2024-03-12 21:56:20754,536
0
754,536Form 4
11Subramanian Romesh
Chief Scientific Officer
10% Owner
2020-09-18 17:12:38694,434
0
694,434Form 4
12CureDuchenne Ventures LLC
10% Owner
2020-09-23 19:05:52602,972
0
602,972Form 4
13Cox John
CEO & President
2026-03-06 16:08:22374,145
72,000
446,145Form 4
14Beskrovnaya Oxana
Chief Scientific Officer
2025-03-13 16:08:14195,840
0
195,840Form 4
15Kerr Douglas
Chief Medical Officer
2026-03-06 16:09:00171,606
0
171,606Form 4
16Friedl-Naderer Johanna
Chief Commercial Officer
2026-03-06 16:10:20154,581
0
154,581Form 4
17Farwell Wildon
Chief Medical Officer
2024-08-20 16:27:16143,222
0
143,222Form 4
18McNeill Jonathan
Chief Business Officer
2024-08-20 16:27:39132,106
0
132,106Form 4
19HIGH SUSANNA GATTI
Chief Operating Officer
2024-09-19 16:52:28131,636
0
131,636Form 4
20Lucera Erick
Chief Financial Officer
2026-04-03 16:10:06125,373
0
125,373Form 4
21Scalzo Richard William
SVP, Head of Finance & Admin.
2025-03-13 16:08:57122,330
0
122,330Form 4
22Karnani Vikram
Director
2025-12-23 16:08:0359,665
0
59,665Form 4
23Incerti Carlo
Director
2025-06-03 21:38:0535,000
0
35,000Form 4
24HURWITZ EDWARD
Director
2025-06-03 21:41:1035,000
0
35,000Form 4
25Lubner David Charles
Director
2025-06-03 21:40:3535,000
0
35,000Form 4
26Stehman-Breen Catherine
Director
2025-06-03 21:37:2035,000
0
35,000Form 4
27Posner Brian S
Director
2026-04-01 16:27:5115,500
0
15,500Form 4
28Klein Lawrence Otto
Director
2022-07-06 18:20:167,222
0
7,222Form 4
29RA CAPITAL MANAGEMENT L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
2025-11-14 16:14:450
0
0Form 13G